Lifeboat Foundation

Injection of human neural stem cells into the spinal cord of people with amyotrophic lateral sclerosis (ALS) was found safe and did not cause adverse effects even two years after the transplant, results from a Phase 1 clinical trial show.

Trial findings were published in the study, “Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome,” in the journal Stem Cells Translational Medicine.

Local health officials say cheap charlatans are likely using contaminated equipment.

Forget stitches and old-school sutures. The Air Force is funding scientists who are using nano-technology and lasers to seal up wounds at a molecular level. It might sound like Star Trek tech, but it’s actually the latest in a series of ambitious Pentagon efforts to create faster, more effective methods of treating war-zone injuries. Last \[…\].

A new Cornell University-led study finds that the genome for a widely researched worm, on which countless studies are based, was flawed. Now, a fresh genome sequence will set the record straight and improve the accuracy of future research.

When scientists study the genetics of an organism, they start with a standard genome sequenced from a single strain that serves as a baseline. It’s like a chess board in a chess game: every board is fundamentally the same.

One model organism that scientists use in research is a worm called Caenorhabditis elegans. The worm—the first multicellular eukaryote (animal, plant or fungus) to have its genome sequenced—is easy to grow and has simple biology with no bones, heart or circulatory system. At the same time, it shares many genes and molecular pathways with humans, making it a go-to model for studying gene function, drug treatments, aging and human diseases such as cancer and diabetes.

Continue reading “Scientists create new standard genome for heavily studied worm” »

People who have bipolar disorder may be more likely to later develop Parkinson’s disease than people who do not have bipolar disorder, according at a study published in the May 22, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

“Previous studies have shown a relationship between depression and Parkinson’s disease, but few studies have looked at whether there is a relationship between bipolar disorder and Parkinson’s,” said study author Mu-Hong Chen, MD, Ph.D., of Taipei Veterans General Hospital in Taiwan.

For the study, researchers examined a national Taiwanese health database for people were diagnosed with bipolar disorder between 2001 and 2009 and who had no history of Parkinson’s disease, for a total of 56,340 people. They were matched with 225,360 people of the same age, sex and other factors who had never been diagnosed with bipolar disorder or Parkinson’s disease as a control group. Then the two groups were followed until the end of 2011.

Continue reading “Bipolar disorder may be linked to Parkinson’s disease” »

In the summer of 2018, a team led by MIT researchers reported in the journal Nature that they had successfully embedded electronic devices into fibers that could be used in fabrics or composite products like clothing, airplane wings, or even wound dressings. The advance could allow fabrics or composites to sense their environment, communicate, store and convert energy, and more.

Research breakthroughs typically take years to make it into final products—if they reach that point at all. This particular research, however, is following a dramatically different path.

By the time the unique fiber advance was unveiled last summer, members of Advanced Functional Fabrics of America (AFFOA), a not-for-profit near MIT, had already developed ways to increase the throughput and overall reliability of the process. And, staff at Inman Mills in South Carolina had established a method to weave the advanced fibers using a conventional, industrial manufacturing-scale loom to create fabrics that can use light to both broadcast and receive information.

Continue reading “Production of more than 250,000 chips embedded within fibers in less than a year” »

The latest market report published by Credence Research, Inc. “Global Plant Stem Cell Market for Nutrition – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the plant stem cell market for nutrition was valued at USD 324.0 Mn in 2015, and is expected to reach USD 1,299.7 Mn by 2022, expanding at a CAGR of 21.3% from 2016 to 2022.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/57974

Regenerative medicine and stem cells are often uttered within the same breath, for good reason.

In animal models, stem cells have reliably reversed brain damage from Parkinson’s disease, repaired severed spinal cords, or restored damaged tissue from diabetes, stroke, blood cancers, heart disease, or aging-related tissue damage. With the discovery of induced pluripotent stem cells (iPSCs), in which skin and other tissue can be reversed into a stem cell-like state, the cells have further been adapted into bio-ink for 3D printing brand new organs.

Continue reading “New Progress in Stem-Cell-Free Regenerative Medicine” »

Naturopaths have long been obsessed with a gene called MTHFR. Now vaccine skeptics are testing for it too.